Skip to main content

Table 1 Patient and disease charateristics

From: Prospective assessment of the quality of life before, during and after image guided intensity modulated radiotherapy for prostate cancer

Categorical characteristic

No. patients n = 87

Percent

 T-stage

  ≤ T2a

17

19

  T2b

5

6

  ≥ T2c

65

75

 Gleason Score

  6

12

14

  7

49

56

  ≥ 8

26

30

 Risk group

  Low

0

0

  Intermediate

14

16

  High

73

84

 Type of ADT

  GnRH agonist

86

99

  Antiandrogen

1

1

Continuous characteristic

Median

Range

 PSA (ng/ml)

11

3.1–91.0

 Age (yr)

67

50–75